All posts

Follow Us

LinkedInInstagramX
Quarterly ResultsArchiveLast updated 23 October 20263 min read

Mphasis (MPHASIS) Q1 FY27 Profit Dips as Costs Bite Into Strong Revenue Growth

The IT services firm posted 17.5% revenue growth but saw its profit margin contract, weighed down by acquisition costs and investments for future deals.

By Abhinav Swaroop, Chief Business Officer Hexawealth · Created 23 October 2026

Mphasis started FY27 with robust 17.5% revenue growth, yet net profit fell sequentially. The quarter highlights a trade-off: strong AI-led deal wins are driving the top line, but integration costs and strategic investments are squeezing near-term profitability.

Mphasis entered its new fiscal year with a clear signal that growth is back on the menu. The IT services firm reported a robust 17.5% year-on-year jump in revenue, powered by a fifth straight quarter of strong deal wins. Yet, the bill for that expansion arrived promptly, as profitability took a sequential hit, revealing the cost of building for the future.

The numbers tell a story of two speeds. Revenue reached ₹4,384.05 crore, up 3.3% from the previous quarter. Profit after tax, however, slipped 3.9% sequentially to ₹489.51 crore. The net profit margin contracted to 11.2%, down 60 basis points from a year ago and 80 points from the March quarter.

Revenue (₹ Cr)

Profit (₹ Cr)

Net Margin (%)

MetricCurrentQ1 FY27 (Jun '26)PreviousQ4 FY26 (Mar '26)
Revenue (₹ Cr)
4,384.05
4,242.67
Profit (₹ Cr)
489.51
509.64
Net Margin (%)
11.2
12.0

The Price of a Growing Pipeline

Management, cited by outlets like QuarterMark and SAHI, pointed to two main cost pressures. About 35 basis points of the margin squeeze came from integrating the recent acquisition of Theory and Practice (TAP). The rest was an investment in building delivery capacity and lower utilization ahead of expected demand. In essence, Mphasis is spending now to capture the growth from its record $461 million in new contract wins, 63% of which were AI-led.

The revenue growth itself was broad-based. According to an Investing.com analysis of the investor presentation, the Americas region drove the expansion with an 11.4% YoY rise. The Banking and Financial Services vertical, the company's largest, grew 9.4% YoY, while Insurance surged 17.8%.

A Test of Execution in Q2

The critical question is how long this margin pressure lasts. Management has held its full-year EBIT margin guidance steady at 14.75%-15.75%, expressing confidence that the current costs are temporary investments. They have set a high bar for the next quarter, projecting Q2 will deliver the strongest sequential constant-currency growth in three years.

The promise is that accelerating revenue will absorb the upfront costs. However, working capital showed some strain, with Days Sales Outstanding rising to 95 days. The company expects this to improve through the year, but it underscores the cash flow impact of funding new, large deals.

Key Points

  • Revenue growth accelerated to 17.5% YoY, supported by $461 million in new TCV wins, with nearly two-thirds being AI-led.
  • Profitability faced near-term pressure, with net profit down 3.9% QoQ and margins contracting due to TAP acquisition costs and investments in delivery capacity.
  • Management maintained its full-year margin guidance and expects Q2 to post the best sequential growth in three years, betting on revenue acceleration to offset current costs.
  • The Direct business, which excludes the legacy DXC channel, grew 9.9% YoY, indicating healthy underlying demand for Mphasis's own offerings.

Hexa Perspective

This quarter frames the classic growth-versus-profitability trade-off. Mphasis is demonstrably winning in the market, with its AI-led Tria platform resonating and the deal pipeline at a record high. The 70% AI-led pipeline, as reported by Investing.com, suggests this momentum is structural.

The squeeze, therefore, looks like a planned cost of scaling. The risk is one of timing: if the projected Q2 revenue acceleration is softer than expected, the margin band could be tested, and the 'investment' narrative would weaken. For now, the market is being asked to trust that today's margin compression is the direct fuel for tomorrow's growth engine.

Share or follow HexaWealth

Also read

Want this applied to your portfolio?

Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.

Frequently asked questions

What were Mphasis's Q1 FY27 results?
For Q1 FY27, Mphasis reported revenue of ₹4,384.05 crore, a 17.5% increase from the same quarter last year. Profit after tax was ₹489.51 crore, up 10.8% year-on-year but down 3.9% from the previous quarter. The net profit margin contracted to 11.2%.
Did Mphasis's profit rise or fall in Q1 FY27?
Mphasis's profit rose 10.8% compared to Q1 FY26. However, it fell 3.9% compared to the immediate previous quarter (Q4 FY26), as the company absorbed costs related to an acquisition and investments in new deal capacity.
What is Mphasis's revenue for Q1 FY27?
Mphasis's revenue for the first quarter of FY27, ended June 2026, was ₹4,384.05 crore. This represents a 17.5% year-on-year growth and a 3.3% sequential increase from the March 2026 quarter.
Why did Mphasis's profit margin decline in Q1 FY27?
Mphasis's net profit margin declined by 60 basis points year-on-year to 11.2%. Management, cited by outlets like QuarterMark, attributed the pressure to costs from integrating the TAP acquisition and investments in building delivery capacity for expected future growth from recent deal wins.
How strong were Mphasis's new deal wins in the quarter?
Mphasis secured $461 million in new Total Contract Value (TCV) wins in Q1 FY27, marking its fifth consecutive quarter above $400 million. According to reports, 63% of these new wins were driven by AI-led projects.
What is Mphasis's guidance for FY27?
Mphasis maintained its full-year FY27 guidance. It expects high single-digit to low double-digit constant-currency revenue growth, an EBIT margin between 14.75% and 15.75%, and operating cash flow conversion of about 80% of net income.
Which business segment grew the fastest for Mphasis?
According to an analysis by Investing.com, the Insurance vertical showed the fastest year-on-year growth among major segments at 17.8%. The Americas geographic region was the primary growth driver, with revenue up 11.4% year-on-year.
What is the outlook for Mphasis's profit margins?
Management expects margin pressure to be temporary, linked to upfront investments. They have held the full-year margin guidance band steady, anticipating that revenue acceleration in the coming quarters will absorb these costs and lead to normalization.
How did Mphasis's cash flow perform in Q1?
Operating cash flow was $39 million for the quarter, as reported by QuarterMark. Days Sales Outstanding (DSO) increased to 95 days, a working capital headwind that management expects to improve through the rest of the fiscal year.
Did institutional investors change their stake in Mphasis after Q1 results?
Available data from Stockfin.ai shows institutional holdings remained stable. DII (Domestic Institutional Investor) holdings were at 45.31% in Q1 FY27, while FII (Foreign Institutional Investor) holdings were steady around 19.5%, indicating continued institutional confidence.